HIV Viral Load Monitoring in Resource-Limited Regions: Optional or Necessary?
Garcia de la Vega, F
AffiliationMedecins sans Frontieres, Access to Medicines Campaign, Geneva, 1211, Switzerland. email@example.com
MetadataShow full item record
JournalClinical Infectious Diseases
AbstractAlthough it is a standard practice in high-income countries, determination of the human immunodeficiency virus (HIV) load is not recommended in developing countries because of the costs and technical constraints. As more and more countries establish capacity to provide second-line therapy, and as costs and technological constraints associated with viral load testing decrease, the question of whether determination of the viral load is necessary deserves attention. Viral load testing could increase in importance as a guide for clinical decisions on when to switch to second-line treatment and on how to optimize the duration of the first-line treatment regimen. In addition, the viral load is a particularly useful tool for monitoring adherence to treatment, performing sentinel surveillance, and diagnosing HIV infection in children aged <18 months. Rather than considering viral load data to be an unaffordable luxury, efforts should be made to ensure that viral load testing becomes affordable, simple, and easy to use in resource-limited settings.
- Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings.
- Authors: Lynen L, Van Griensven J, Elliott J
- Issue date: 2010 Jan
- The measurement of HIV-1 viral load in resource-limited settings: how and where?
- Authors: Rouet F, Rouzioux C
- Issue date: 2007
- Viral load testing in resource-limited settings.
- Authors: Schooley RT
- Issue date: 2007 Jan 1
- Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.
- Authors: Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF, Katabira E, Colebunders R, Quinn TC, Ronald A, Thomas DL, Kekitiinwa A, Academic Alliance for AIDS Care and Prevention in Africa.
- Issue date: 2007 Oct 1
- Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
- Authors: Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W
- Issue date: 2007 Feb 1